WST - Mark Eric Green Expands Holdings With $288K West Pharmaceutical Servs Stock Options Acquisition | Benzinga
Mark Eric Green, President at West Pharmaceutical Servs (NYSE:WST), reported acquisition of company stock options on February 22, according to a new SEC filing.
What Happened: Uncovered in a Form 4 filing on Thursday with the U.S. Securities and Exchange Commission, Green, President at West Pharmaceutical Servs, executed an insider options move. This move consisted of acquiring stock options for 25,221 shares of WST, granting Green the right to purchase the company's stock at an exercise price of $350.18 per share.
Currently, West Pharmaceutical Servs shares are trading up 0.48%, priced at $361.63 during Friday's morning. This values Green's 25,221 shares at $288,780.
Discovering West Pharmaceutical Servs: A Closer Look
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
West Pharmaceutical Servs: Financial Performance Dissected
Revenue Growth: West Pharmaceutical Servs's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company ...